Filing Details

Accession Number:
0001209191-22-062647
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-23 17:05:59
Reporting Period:
2022-11-01
Accepted Time:
2022-12-23 17:05:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-01 20 $2.53 18,808 No 4 P Direct
Common Stock Acquisiton 2022-11-02 20 $2.54 18,828 No 4 P Direct
Common Stock Acquisiton 2022-11-03 20 $2.44 18,848 No 4 P Direct
Common Stock Acquisiton 2022-11-04 20 $2.42 18,868 No 4 P Direct
Common Stock Acquisiton 2022-11-07 20 $2.45 18,888 No 4 P Direct
Common Stock Acquisiton 2022-11-08 20 $2.42 18,908 No 4 P Direct
Common Stock Acquisiton 2022-11-09 20 $2.37 18,928 No 4 P Direct
Common Stock Acquisiton 2022-11-10 20 $2.37 18,948 No 4 P Direct
Common Stock Acquisiton 2022-11-11 20 $2.32 18,968 No 4 P Direct
Common Stock Acquisiton 2022-11-14 20 $2.32 18,988 No 4 P Direct
Common Stock Acquisiton 2022-11-15 20 $2.35 19,008 No 4 P Direct
Common Stock Acquisiton 2022-11-16 20 $2.31 19,028 No 4 P Direct
Common Stock Acquisiton 2022-11-17 20 $2.29 19,048 No 4 P Direct
Common Stock Acquisiton 2022-11-18 20 $2.27 19,068 No 4 P Direct
Common Stock Acquisiton 2022-11-21 20 $2.38 19,088 No 4 P Direct
Common Stock Acquisiton 2022-11-22 20 $2.37 19,108 No 4 P Direct
Common Stock Acquisiton 2022-11-23 20 $2.29 19,128 No 4 P Direct
Common Stock Acquisiton 2022-11-25 20 $2.31 19,148 No 4 P Direct
Common Stock Acquisiton 2022-11-28 20 $2.37 19,168 No 4 P Direct
Common Stock Acquisiton 2022-11-29 20 $2.34 19,188 No 4 P Direct
Common Stock Acquisiton 2022-11-30 20 $2.32 19,208 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.